Cardinal Health to buy Strive Medical, AdaptHealth's diabetes health business for $360M
fiercehealthcare - The pharmaceuticals and specialty products distributor plans to buy AdaptHealth's diabetes health business unit and medical supply provider Strive Medical in separate deals worth $360 million.
AI Summary: Cardinal Health agreed to buy AdaptHealth/Strive Medical’s diabetes health business for roughly $360 million and pursue additional acquisitions to expand its at‑home care portfolio. The moves aim to accelerate home‑based services and chronic disease support, reflecting a broader industry push to shift care out of hospitals and into patients' living rooms.
$10B M&A Deal Pays Off With GSK’s First Lung Cancer Drug Approval
Frank Vinluan / medcitynews - GSK drug Jideytro received FDA approval for treating advanced cases of non-small cell lung cancer driven by ROS1 alterations. This molecule came from Nuvalent, which GSK recently acquired for $10.6 billion. The post $10B M&A Deal Pays Off With GSK’s First…
AI Summary: GSK has won FDA approval for its first lung cancer drug, a gene-targeting therapy that validates the company’s heavy investment and recent M&A strategy. The approval follows pivotal trial evidence of clinical benefit and positions GSK competitively in thoracic oncology, offering a new therapeutic choice for patients with the relevant molecular profile.